23andMe president steps down, will remain on the board

Andy Page, the president of at-home genetic testing service 23andMe, will leave the company in December but will remain on the company’s board of directors, Recode reports.

Advertisement

In a letter to employees, 23andMe CEO Anne Wojcicki wrote, “Andy and I recognize 23andMe is at a stage of strength and maturity where it would benefit from one single leader. Moving forward, Andy’s direct reports will report to me.”

Recode was not aware of where, if anywhere, Mr. Page plans to work next.

Mr. Page previously served as president of the Gilt Groupe, CFO of PlayPhone and CFO of StubHub.

More articles on health IT:
Prediction: Ransomware, Internet of Things dynamics to change in 2017, says Kaspersky Lab researchers
Viewpoint: Organizations that leverage AI will stay competitive
Google to develop AI team for Google Cloud

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.